Penn Medicine experts will be speaking and presenting data on the latest advances in cancer research and treatment at the American Association for Cancer Research’s 2014 Annual Meeting from April 5th through April 9th in San Diego. The program covers every aspect of cancer – from molecular biology, translational and clinical studies, epidemiology, and prevention to survivorship and patient advocacy.
Experts from Penn's Abramson Cancer Center are available to comment on a wide range of cancer research topics. To arrange interviews, please contact Steve Graff at stephen.graff@uphs.upenn.edu or 215-301-5221. Follow us on Twitter at @PennMedNews.
Watch this space for a news release as embargoes lift during the meeting.
News Releases
Penn Medicine Physician to Co-Lead Stand Up to Cancer "Dream Team" to Fight Pancreatic Cancer
Plenary Talk
Carl H. June, MD, the Richard W. Vague Professor in Immunotherapy in the department of Pathology and Laboratory Medicine and director of Translational Research at the Abramson Cancer Center, will be delivering a plenary talk titled “Engineering T cells for cancer: CARs in the clinic” on Monday, April 7 at 8:15 am PST. An expert in gene therapy and immunotherapeutic approaches to cancer treatment, Dr. June leads the team that published research showing sustained remissions among both adult and pediatric patients with advanced leukemias who were treated with genetically engineered versions of their own T cells. His team is developing strategies to expand this personalized approach into ovarian and pancreatic cancers and mesothelioma.
Announcements:
Peter C. Nowell, MD, the Gaylord P. and Mary Louise Harnwell professor emeritus in the Department of Pathology and Laboratory Medicine, will be formally inducted into the 2014 class of elected fellows of the AACR Academy on Friday, April 4.
M. Celeste Simon, PhD, a professor in the Department of Cell and Development Biology and scientific director and investigator at the Abramson Family Cancer Research Institute, has been elected to the AACR Board of Directors, and will assume her role at the start of the meeting on April 5.
Related Links
Abramson Cancer Center
Perelman School of Medicine
University of Pennsylvania Health System
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, excellence in patient care, and community service. The organization consists of the University of Pennsylvania Health System and Penn’s Raymond and Ruth Perelman School of Medicine, founded in 1765 as the nation’s first medical school.
The Perelman School of Medicine is consistently among the nation's top recipients of funding from the National Institutes of Health, with $550 million awarded in the 2022 fiscal year. Home to a proud history of “firsts” in medicine, Penn Medicine teams have pioneered discoveries and innovations that have shaped modern medicine, including recent breakthroughs such as CAR T cell therapy for cancer and the mRNA technology used in COVID-19 vaccines.
The University of Pennsylvania Health System’s patient care facilities stretch from the Susquehanna River in Pennsylvania to the New Jersey shore. These include the Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Chester County Hospital, Lancaster General Health, Penn Medicine Princeton Health, and Pennsylvania Hospital—the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.
Penn Medicine is an $11.1 billion enterprise powered by more than 49,000 talented faculty and staff.